In depth
Systemic sclerosis: common questions
The largest exercise trial ever run in this disease randomized 34 people. Knowing that changes how you read the confident advice that gets built on top of it. Every answer below is shaped by a field that small, and this page says so rather than hiding it from you.
What the research found.
In 34 people with limited cutaneous systemic sclerosis, two interval training protocols were tested against a control group. Peak oxygen uptake rose in both exercise groups over 12 weeks of twice-weekly training. That is the largest exercise trial this disease has, and it's worth knowing that before you read anything else here.
Mitropoulos and colleagues, Arthritis Research and Therapy, 2018
In that trial, transcutaneous oxygen tension rose in the arm-cranking group only. The effect size was 0.93, which is large, and it didn't reach statistical significance at a P value of 0.59. That combination is what a small trial looks like when it can't answer its own question.
Mitropoulos and colleagues, Arthritis Research and Therapy, 2018
A specialist group position paper advocates for exercise as a systemic and targeted disease-modifying treatment in systemic sclerosis. Alongside that it sets out a research agenda for the field. It reports no patient outcome of its own, and that's the part that gets lost when the phrase travels.
Pettersson and colleagues, Best Practice and Research Clinical Rheumatology, 2021
In a randomized comparison in systemic sclerosis, silver-lined gloves and ordinary gloves performed alike on the burden of Raynaud's. Both of them reduced the condition score from 6.4 to 3.9. So gloves helped substantially and the expensive kind didn't help more, which answers a purchasing question directly.
A review of resistance exercise in systemic sclerosis reported improved muscle strength, reduced physical disability, and improved quality of life in its participants. The population it covered was about 85 percent female, which is typical of this disease. Our record doesn't hold the effect sizes behind any of those three findings, so no number appears here.
How small the evidence base is
The largest exercise trial in systemic sclerosis randomized 34 people. That single fact does more to explain the state of advice in this condition than anything else on this page, because a great deal gets built on a base that thin. Keeping it in mind makes the rest of this page read differently.
Those 34 people had limited cutaneous disease and were randomized to cycling interval training, arm-cranking interval training, or a control group, twice weekly for 12 weeks. Peak oxygen uptake rose in both exercise arms, which is what a training program should do and is worth confirming in a disease where people are often told to be careful. That much is solid, and it's the clearest finding in the whole literature.
The rest of the field is a narrative review of resistance exercise whose effect sizes our record doesn't hold, a position paper with no patient outcomes, and a randomized comparison of glove types. That's the whole of it, and every answer below is shaped by that. Nothing has been left out to make the field look thinner than it is.
The disease-modifying claim, corrected
You'll see it stated that exercise is a disease-modifying treatment in systemic sclerosis. That phrase traces to a specialist group position paper, which states that it recognizes the scientific basis of and advocates for education and research into exercise as a systemic and targeted disease-modifying treatment, and sets out preliminary guidance plus a research agenda. The wording of that sentence is what the whole misunderstanding turns on.
Read carefully, that's a call for research and not a report of results. The paper reports no patient outcome of its own. Its account of exercise downregulating inflammatory and fibrotic pathways is the authors' overview of the underlying biology, not something measured in that document.
That doesn't make the position paper wrong or unimportant. It's a reasonable argument from mechanism made by people who know this disease well, and arguing from mechanism is how research agendas get written. What it isn't is evidence that exercise changed the course of systemic sclerosis in anybody.
The vascular measurement, and why it doesn't settle anything
The most interesting result in the interval training trial was transcutaneous oxygen tension, which estimates oxygen delivery to the skin and speaks directly to the vascular problem at the center of this disease. It rose in the arm-cranking group only, with an effect size of 0.93, which is large. The P value was 0.59.
That combination is what a small trial looks like when it can't answer its own question. Thirty-four participants split three ways leaves almost no power to detect anything, and a P value of 0.59 is nowhere near the conventional threshold. Quoting the effect size on its own would make an unresolved question look settled.
The right conclusion is that somebody should run a larger trial of this particular question. That's a less satisfying answer than either a confident yes or a confident no, and it's what the evidence supports. It hasn't been run yet, and until somebody does the question stays open.
Raynaud's, where there is a clean answer
Raynaud's phenomenon is close to universal in this disease and it's the symptom people most want addressed. A randomized comparison put silver-lined gloves against ordinary gloves and found no difference between the two types on the Raynaud's condition score. Both of them reduced it from 6.4 to 3.9.
That's a useful result in two separate directions at once. Gloves helped substantially, which is worth knowing for anyone who has wondered whether keeping warm does anything measurable at all. The expensive form didn't help more, which answers a purchasing question directly.
The digital ulcer figures from that same trial need their limits attached. Three patients developed new ulcers with normal gloves against one with silver-lined gloves, an odds ratio of 3.2 with a confidence interval ranging from 0.32 to 31.1. An interval that wide contains everything from substantial benefit to substantial harm, so it establishes nothing at all.
What counts more than any of this
Lung involvement and pulmonary hypertension are the complications that determine how this disease goes, which makes new breathlessness the symptom deserving the least benefit of the doubt. Attributing it to being unfit is the mistake this page most wants to prevent. Mention it, and let somebody who knows your case work out whether it counts.
Fingertip sores and ulcers need mentioning promptly, because they heal badly and because they mark more serious vascular disease. Skin tightening changes what grips and what range of movement are available, which is why a physiotherapist who has seen systemic sclerosis is worth more here than a general program. Both of those are worth raising before they become the reason for an urgent appointment.
Diet is complicated in this condition for reasons that have nothing to do with inflammation. Reflux, swallowing difficulty, and problems with gut motility and absorption are recognized parts of the disease, and they affect what and how you can eat far more than any theory about anti-inflammatory foods. Those are practical problems worth raising.
Common misconceptions.
Myth. Exercise modifies this disease.
Reality. That claim traces to a position paper advocating for research into exercise as a disease-modifying treatment, not to a trial showing it is one. The paper reports no patient outcome of its own. Its mechanistic account is an overview of biology rather than a measurement, and it's a reasonable argument from mechanism by people who know the disease. It isn't evidence that exercise changed anybody's course.
Myth. Exercise improves circulation to the skin.
Reality. The trial that measured it directly found skin oxygen tension rising in one exercise arm with an effect size of 0.93, which is large, and a P value of 0.59, which is nowhere near significance. With 34 participants split three ways, that trial lacked the power to answer its own question. A large effect that misses significance that far is a reason to run a bigger trial.
Myth. Special gloves help Raynaud's more than ordinary ones.
Reality. A randomized comparison in systemic sclerosis found no difference between silver-lined and ordinary gloves on the Raynaud's condition score, while both reduced it from 6.4 to 3.9. The warmth is doing the work rather than the fiber. That's a direct answer to a purchasing question, which is rare in this area.
Myth. Breathlessness in this disease is being unfit.
Reality. Lung involvement and pulmonary hypertension are the complications that determine the outlook in systemic sclerosis, which makes new breathlessness the symptom that deserves the least benefit of the doubt. The interval training trial recruited people with limited cutaneous disease specifically, so even its safety findings don't speak to everyone with this diagnosis. Mention new breathlessness, and let somebody who knows your case decide whether it counts.
Questions patients ask.
Is exercise safe with systemic sclerosis?
Nothing in the trials suggests harm, and the trials were small and selected. The largest randomized 34 people with limited cutaneous disease to cycling intervals, arm-cranking intervals, or control, twice weekly for 12 weeks, and peak oxygen uptake rose in both exercise arms. That selection counts, because it doesn't speak to people with diffuse disease or significant lung involvement.
Does exercise change the disease itself?
No trial has shown that. The claim circulates because a specialist group position paper states that it recognizes the scientific basis of and advocates for education and research into exercise as a systemic and targeted disease-modifying treatment. That paper reports no patient outcome of its own, and its account of downregulating inflammatory and fibrotic pathways is the authors' overview of biology rather than a measurement.
What about the circulation in my fingers?
That's what the largest trial tried to measure and couldn't. Transcutaneous oxygen tension rose in the arm-cranking group with an effect size of 0.93 and a P value of 0.59, so a large apparent effect missed significance completely in 34 people. The right conclusion is that a bigger trial should be run, and the wrong one is to quote the effect size as though the finding were established.
Do special gloves help my Raynaud's?
Gloves help and the expensive ones don't help more. A randomized comparison of silver-lined against ordinary gloves in systemic sclerosis found no difference between the types, and both reduced the Raynaud's condition score from 6.4 to 3.9. Three patients developed new digital ulcers with normal gloves against one with silver-lined gloves, an odds ratio of 3.2 with a confidence interval from 0.32 to 31.1, far too wide to conclude anything.
Is resistance training worth doing?
A review of resistance exercise in this condition reported improved muscle strength, reduced physical disability, and improved quality of life, in a population about 85 percent female. Our record for it holds no effect sizes, so the size of those improvements isn't on file here. The direction is favorable and the magnitude is unrecorded, and both are worth knowing.
Is there a diet for systemic sclerosis?
No disease-specific nutrition trial exists. What complicates diet here more than in most rheumatic disease is the gut, since reflux, swallowing difficulty, and problems with gut motility and absorption are all recognized parts of this condition. Those are practical problems worth raising with your team, and they're a different question from whether a particular way of eating changes the disease.
How much exercise, and what kind?
The trials used supervised programs twice weekly over 12 weeks, and the interval protocols were cycling and arm cranking. One resistance program isn't described in enough detail in our record to reproduce. Those parameters describe what has been tested rather than what's optimal, because doses have never been compared in this condition. Building from your current capacity with someone who knows the disease is the sensible route.
What should I be careful about?
New breathlessness, first, because lung involvement and pulmonary hypertension determine the outlook here and being unfit is the wrong first explanation. Fingertip sores and ulcers need mentioning promptly because they heal badly. Skin tightening changes what grips and what range of movement are available, which is a reason to work with a physiotherapist who has seen this disease rather than to follow a general program.
What should I take to my next appointment?
Breathlessness and any change in exercise tolerance, difficulty swallowing or new reflux, fingertip sores, and any change in the skin. Those four cover the organs that decide how this disease goes. Raynaud's attacks are worth counting, since the trials use an attack count and your team can use one too.
References.
- Mitropoulos A; Gumber A; Crank H et al. The effects of upper and lower limb exercise on the microvascular reactivity in limited cutaneous systemic sclerosis patients. Arthritis Research & Therapy. 2018;20. 10.1186/s13075-018-1605-0Randomised controlled trial
- Pettersson H; Alexanderson H; Poole JL et al. Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS). Best practice & research. Clinical rheumatology. 2021;35:101695. 10.1016/j.berh.2021.101695Position paper
- Liem S; Hoekstra E; Bonte-Mineur F et al. The effect of silver fibre gloves on Raynaud’s phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trial. Rheumatology. 2022;62:SI74-SI81. 10.1093/rheumatology/keac243Multicentre
- Mallmann A; de Moraes D; Dória L et al. Effects of interventions with resistance exercises on muscle strength, physical disability, and quality of life in systemic sclerosis patients: a systematic review with meta-analysis. Advances in Rheumatology. 2025;65. 10.1186/s42358-025-00468-1SR + MA
- Daniels J; Pauling J; Eccleston C. Behaviour change interventions for the management of Raynaud’s phenomenon: a systematic literature review. BMJ Open. 2018;8:e024528. 10.1136/bmjopen-2018-024528Systematic literature review of RCTs with narrative synthesis
This page gathers the published research on this subject into one place. The studies behind it were published between 1989 and 2026, and every figure links to the paper it came from. Those studies were peer reviewed. This summary of them was not. Dr. Sarah Luebker is reviewing these pages one at a time and has not reached this one yet, so it carries no medical review date and nothing here is her opinion or her advice to you. Each page gets updated as she reaches it. It is here in the meantime because the science is worth having in one organized place that is easy to find and easy to read. Talk to your own clinician before acting on any of it.